209 CONFIRMING PHASE III CLINICAL TRIAL TO STUDY THE EFFICACY OF A P.A.F. ANTAGONIST, BN 52021 [BN], IN REDUCING MORTALITY OF PTS WITH SEVERE GRAM-NEGATIVE SEPSIS [GNS]